Accueil
Détail de l'auteur
Auteur D. HORYNIAK |
Documents disponibles écrits par cet auteur (5)
Ajouter le résultat dans votre panier Faire une suggestion Affiner la recherche
Article : Périodique
BACKGROUND: A systematic review was conducted to determine whether behavioural interventions are effective in preventing transmission of hepatitis C virus (HCV) amongst people who inject drugs. METHODS: Medline, EMBASE, the Cochrane Clinical T[...]Article : Périodique
P. K. NELSON ; B. M. MATHERS ; B. COWIE ; H. HAGAN ; D. C. DES JARLAIS ; D. HORYNIAK ; L. DEGENHARDT |BACKGROUND: Injecting drug use is an important risk factor for transmission of viral hepatitis, but detailed, transparent estimates of the scale of the issue do not exist. We estimated national, regional, and global prevalence and population siz[...]Article : Périodique
D. HORYNIAK ; M. STOOVE ; L. DEGENHARDT ; C. AITKEN ; T. KERR ; P. DIETZE |Background: Changes in drug market characteristics have been shown to affect drug use patterns but few studies have examined their impacts on injecting initiation experiences and subsequent patterns of injecting drug use (IDU). Methods: We coll[...]Article : Périodique
A. GUISE ; D. HORYNIAK ; J. MELO ; R. MCNEIL ; D. WERB |Background and aim: Understanding the experience of initiating injection drug use and its social contexts is crucial to inform efforts to prevent transitions into this mode of drug consumption and support harm reduction. We reviewed and synthesi[...]Article : Périodique
D. HORYNIAK ; P. DIETZE ; B. LARANCE ; A. WINSTOCK ; L. DEGENHARDT |BACKGROUND Diversion and injection of buprenorphine (Subutex®) and buprenorphine-naloxone (Suboxone®) have been well documented. Recent international research and local anecdotal evidence suggest that these medications are also used by other rou[...]